CEL-SCI Corp. (CVM)
1.445
-0.26
(-15.00%)
USD |
NYAM |
May 11, 16:00
1.245
-0.20
(-13.84%)
After-Hours: 20:00
CEL-SCI Total Liabilities (Quarterly) : 11.76M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Agenus, Inc. | 504.66M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Anika Therapeutics, Inc. | 45.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.89M |
| Shareholders Equity (Quarterly) | 11.14M |
| Debt to Equity Ratio | 0.8175 |
| Current Ratio | 1.395 |
| Net Debt Paydown Yield | 1.14% |